Communiqué de presse
Domain Therapeutics strengthens leadership team to spearhead global development and North American expansion as the leading GPCR immuno-oncology company
Michael Gottlieb appointed as Chairman of the Board of Directors Dr. Anthony Johnson appointed as President and Chief Executive Officer […]